BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

647 related articles for article (PubMed ID: 17641677)

  • 1. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization.
    Chang MC; Uang BJ; Tsai CY; Wu HL; Lin BR; Lee CS; Chen YJ; Chang CH; Tsai YL; Kao CJ; Jeng JH
    Br J Pharmacol; 2007 Sep; 152(1):73-82. PubMed ID: 17641677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production.
    Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC
    Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet effect of phloroglucinol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
    Chang MC; Chang HH; Chan CP; Chou HY; Chang BE; Yeung SY; Wang TM; Jeng JH
    Toxicol Appl Pharmacol; 2012 Sep; 263(3):287-95. PubMed ID: 22789837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidative and antiplatelet effects of aqueous inflorescence Piper betle extract.
    Lei D; Chan CP; Wang YJ; Wang TM; Lin BR; Huang CH; Lee JJ; Chen HM; Jeng JH; Chang MC
    J Agric Food Chem; 2003 Mar; 51(7):2083-8. PubMed ID: 12643677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of platelet aggregation by areca nut and betel leaf ingredients: roles of reactive oxygen species and cyclooxygenase.
    Jeng JH; Chen SY; Liao CH; Tung YY; Lin BR; Hahn LJ; Chang MC
    Free Radic Biol Med; 2002 May; 32(9):860-71. PubMed ID: 11978487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic investigation of the anti-platelet aggregation activity of ginsenoside Rk₁ reveals attenuated 12-HETE production.
    Ju HK; Lee JG; Park MK; Park SJ; Lee CH; Park JH; Kwon SW
    J Proteome Res; 2012 Oct; 11(10):4939-46. PubMed ID: 22873173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-platelet effects of yuzu extract and its component.
    Yu HY; Park SW; Chung IM; Jung YS
    Food Chem Toxicol; 2011 Dec; 49(12):3018-24. PubMed ID: 22005257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
    Lee JJ; Yu JY; Lee JH; Zhang WY; Kim TJ; Myung CS; Yun YP
    Arch Pharm Res; 2010 Mar; 33(3):387-94. PubMed ID: 20361303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cyclooxygenase activity, platelet aggregation and thromboxane B2 production by two environmental toxicants: m- and o-cresol.
    Chan CP; Yuan-Soon H; Wang YJ; Lan WH; Chen LI; Chen YJ; Lin BR; Chang MC; Jeng JH
    Toxicology; 2005 Mar; 208(1):95-104. PubMed ID: 15664436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization.
    Jin YR; Cho MR; Ryu CK; Chung JH; Yuk DY; Hong JT; Lee KS; Lee JJ; Lee MY; Lim Y; Yun YP
    J Pharmacol Exp Ther; 2005 Jan; 312(1):214-9. PubMed ID: 15328379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet activity of alpha-lipoic acid.
    Lai YS; Shih CY; Huang YF; Chou TC
    J Agric Food Chem; 2010 Aug; 58(15):8596-603. PubMed ID: 20681648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
    Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance".
    Santilli F; Rocca B; De Cristofaro R; Lattanzio S; Pietrangelo L; Habib A; Pettinella C; Recchiuti A; Ferrante E; Ciabattoni G; Davì G; Patrono C
    J Am Coll Cardiol; 2009 Feb; 53(8):667-77. PubMed ID: 19232899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiplatelet effect by p-cresol, a uremic and environmental toxicant, is related to inhibition of reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
    Chang MC; Wang TM; Yeung SY; Jeng PY; Liao CH; Lin TY; Lin CC; Lin BR; Jeng JH
    Atherosclerosis; 2011 Dec; 219(2):559-65. PubMed ID: 21993412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production.
    Chang MC; Chang HH; Wang TM; Chan CP; Lin BR; Yeung SY; Yeh CY; Cheng RH; Jeng JH
    PLoS One; 2014; 9(8):e104310. PubMed ID: 25122505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
    Lee JJ; Jin YR; Lim Y; Hong JT; Kim TJ; Chung JH; Yun YP
    Vascul Pharmacol; 2006 Sep; 45(3):148-53. PubMed ID: 16916624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.